Clinical Trials Logo

Pancreatic Cancer, Adult clinical trials

View clinical trials related to Pancreatic Cancer, Adult.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04002128 Completed - Stomach Neoplasms Clinical Trials

Tracheal Colonization and Outcome After Major Abdominal Cancer Surgery

Start date: January 2008
Phase: N/A
Study type: Interventional

The goals of this study were to investigate whether two anesthesia regimens, with and without N2O, and bacterial colonization influence respiratory complications after major abdominal surgery for cancer.

NCT ID: NCT03152487 Completed - Pancreatic Cancer Clinical Trials

Trial Comparing EUS-guided Radiofrequency Ablation vs. EUS-guided Celiac Plexus Neurolysis

Start date: April 24, 2017
Phase: N/A
Study type: Interventional

Pancreatic cancer is the second most common gastrointestinal malignancy. Abdominal discomfort is a main symptom in patients with pancreatic cancer. Approximately 75% have pain at diagnosis and over 90% in advanced stages. Pain control is an important part of the plan of care for patients with pancreatic cancer.. The celiac plexus is a group of nerves that supply organs in the abdomen. EUS-guided celiac plexus neurolysis (EUS-CPN) has been widely used for pain management in patients with pancreatic cancer. Radiofrequency ablation of celiac ganglia or celiac plexus (EUS-RFA) is also being performed to alleviate abdominal pain in pancreatic cancer patients. However currently no comparative studies exist comparing EUS-CPN with EUS-RFA. The purpose of the study is to compare EUS-CPN with EUS-RFA for pain management in pancreatic patients, in order to determine which technique is better at improving pain in pancreatic cancer patients.

NCT ID: NCT03042442 Completed - Pain Clinical Trials

Relation Between Cachexia, Diabetes and periNeural Invasion in PANcreatic Cancer- Biomarkers Substudy

CDNPAN
Start date: January 1, 2017
Phase:
Study type: Observational

The purpose of this study is to determine the interrelationship between cachexia, neural invasion and diabetes in patients with pancreatic cancer. Thus the investigators propose to identify the protein expression levels of Activin and Midkine in plasma of patients with different stages of pancreatic adenocarcinoma compared with healthy patients and to evaluate the possible correlation with diabetes, tumor size and tumor stage.